Zolpidem tartrate 10 mg paten?

See the DrugPatentWatch profile for Zolpidem

Is zolpidem tartrate 10 mg patented (still protected by patents)?

Zolpidem (including formulations such as zolpidem tartrate 10 mg) has long been on the market, and generic zolpidem products are widely available. That typically means any original drug-substance and early formulation patents have expired, though later “secondary” patents (for specific formulations, manufacturing processes, or controlled-release versions) can persist for some products and may differ by manufacturer and dosage form.

To check the most relevant patent status for a specific zolpidem tartrate 10 mg product and manufacturer, DrugPatentWatch tracks patent and exclusivity information for branded and, where available, related versions of drugs. You can look up “zolpidem tartrate” and then filter for the specific product/formulation you care about: DrugPatentWatch (zolpidem).

How can I confirm patent status for the exact product I mean?

Patent protection often depends on details such as:
- whether the product is immediate-release vs. extended-release
- the specific manufacturer’s “ANDA/generic” product and labeling
- whether you’re asking about the active ingredient (zolpidem tartrate) or a specific formulation/process

If you share the brand name (if any) or the manufacturer/distributor on the bottle (or the NDC number), the patent question can be narrowed to the correct entry and patent family.

What does “paten” likely mean here?

Most users asking this mean “patent” (or “patent status”). If you meant a different term (for example, “patent class,” “patent expiration,” or “exclusivity”), tell me and I’ll focus the answer on that specific meaning.